US Federal Court Blocks Mailing of Mifepristone Abortion Pill

A federal appeals court ruled to block mail delivery of mifepristone, requiring in-person clinic distribution instead of telehealth prescriptions. Manufacturers and advocacy groups are preparing appeals following the significant regulatory shift.